Redhill Biopharma Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Redhill Biopharma Ltd with three other
miscellaneous service companies in Middle East:
sales of 2.68 million Israel Shekels [US$738,790.88 ]
Arcturus Therapeutics Ltd
(73.88 million Israel Shekels [US$20.40 million]
Kitov Pharma Ltd
(3.55 million Israel Shekels [US$981,129.99 ]
of which 100%
was Pain and Hypertension).
Redhill Biopharma Ltd reported sales of 22.36 million Israel Shekels (US$6.17 million)
December of 2019.
decrease of 25.8%
versus 2018, when the company's sales were 30.14 million Israel Shekels.